Search Results

TRAM-34 50mg 50mg  | Purity Not Available

Adooq Bioscience

TRAM-34 is a highly selective blocker of intermediate conductance Ca2+-activated K+ channels (KCa3.1) (Kd = 20 nM). Exhibits 200-1500-fold selectivity over KV, BKCa, KCa2, Na+, CRAC and Cl- channels. Suppresses the reactivation of lymphocytes by mitogenic stimuli.

More Information Supplier Page

TRAM-34 25mg 25mg  | Purity Not Available

Adooq Bioscience

TRAM-34 is a highly selective blocker of intermediate conductance Ca2+-activated K+ channels (KCa3.1) (Kd = 20 nM). Exhibits 200-1500-fold selectivity over KV, BKCa, KCa2, Na+, CRAC and Cl- channels. Suppresses the reactivation of lymphocytes by mitogenic stimuli.

More Information Supplier Page

TRAM-34 100mg 100mg  | Purity Not Available

Adooq Bioscience

TRAM-34 is a highly selective blocker of intermediate conductance Ca2+-activated K+ channels (KCa3.1) (Kd = 20 nM). Exhibits 200-1500-fold selectivity over KV, BKCa, KCa2, Na+, CRAC and Cl- channels. Suppresses the reactivation of lymphocytes by mitogenic stimuli.

More Information Supplier Page

PS-1145 10mg 10mg  | Purity Not Available

Adooq Bioscience

PS-1145 is a highly specific IKB kinase (IKK) inhibitor that efficiently inhibits both basal and induced NF-kB activity in PC cells.

More Information Supplier Page

Firategrast (SB 683699) 50mg 50mg  | Purity Not Available

Adooq Bioscience

Firategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS).

More Information Supplier Page

Firategrast (SB 683699) 5mg 5mg  | Purity Not Available

Adooq Bioscience

Firategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS).

More Information Supplier Page

Firategrast (SB 683699) 25mg 25mg  | Purity Not Available

Adooq Bioscience

Firategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS).

More Information Supplier Page

Firategrast (SB 683699) 10mg 10mg  | Purity Not Available

Adooq Bioscience

Firategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS).

More Information Supplier Page